Active hexose correlated compound (AHCC) is one of a number of evidence-based, non-conventional therapies that can heal the cancer survivor
Living with an “incurable” cancer since 1994 (Multiple Myeloma) and more than 10 years of cancer research have taught me that most cancers patients and survivors do not benefit from an all or nothing approach to cancer management. Treating multiple myeloma as well as other cancers is not strictly conventional/traditional or nonconventional/nontraditional- at least in my experience.
To be clear, HPV is “associated with” multiple myeloma. While studies confirm that HPV (warts) increases the risk of multiple myeloma, there is no discussion that HPV causes MM.
I never thought much about my warts. They never really bothered me much. However once I learned that HPV (warts) increases the risk of multiple myeloma (my cancer), and that AHCC has been shown to eradicate HPV, I decided to supplement with AHCC. While I’ll never know for certain if my AHCC supplementation eradicated my HPV, I have been in complete remission from my MM since 1999.
Active hexose correlated compound (AHCC) is one of a number of evidence-based, non-conventional therapies that can heal the MM patient. According to the articles linked and excerpted below AHCC is a nutritional supplement that can
- increase natural killer cell activity,
- improved the prognosis of patients with liver cancer,
- ease the side effects of chemotherapy enhancing the patients QOL and finally
- possibly eradicate HPV in patients.
Whether you undergo surgery to debulk a tumor, undergo toxic chemotherapy to treat your multiple myeloma and possibly weakening your immune system, you will benefit from evidence-based, non-conventional therapies.
Like curcumin, green tea extract, vitamin D3, milk thistle, grape seed extract, resveratrol and others, it is up to the cancer patient/survivor/caregiver to read studies and decide for him or herself if AHCC is right for their cancer situation.
I am a long-term multiple myeloma survivor and MM cancer coach. To learn more about how supplementation/nutriceuticals can support your health, scroll down the page, post a question or comment and I will reply to you ASAP.
- Long-term MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
What is AHCC?
“Active Hexose Correlated Compound (AHCC) is an alpha-glucan rich nutritional supplement produced from the mycelia of shiitake (Lentinula edodes) of the basidiomycete family of mushrooms, and is not an approved drug…AHCC was originally designed to lower high-blood pressure. However, researchers at Tokyo University found that AHCC increased natural killer (NK) cell activity in cancer patients, and also enhanced the effects of killer T-cells, and cytokines…”
“Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease in the rate of tumor growth in-vitro and in-vivo…These data suggest AHCC can eliminate HPV infections and may have a role in the prevention of HPV-related cancers…According to the CDC several other types of cancer are also HPV related, including: 95% of anal cancer; 60% of oropharyngeal cancer; 65% of vaginal cancer; 50% of vulvar cancer; and 35% of penile cancer.
“A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial. Ten HPV-positive women were treated orally with the extract, AHCC (active hexose correlated compound) once daily for up to six months. Five achieved a negative HPV test result — three with confirmed eradication after stopping AHCC — with the remaining two responders continuing on the study….”
“Recently, AHCC was found to improve the prognosis of hepatocellular carcinoma patients following surgical treatment. We investigated whether AHCC could prolong survival and improve the prognosis of patients with advanced liver cancer…Patients in the AHCC treated-group had a significantly prolonged survival when compared to the control group by Mann-Whitney test (95% CI, p = 0.000). Quality of life in terms of mental stability, general physical health status, and ability to have normal activities were significantly improved after 3 months of AHCC treatment when tested using the Wilcoxon signed-rank test..
This study suggests that AHCC intake could prolong the survival and improve the prognosis of patients with advanced liver cancer and delay the gradual decline of their physiological status.
“These findings suggest that salivary HHV-6 levels may be a good biomarker of QOL in patients during chemotherapy, and that AHCC may have a beneficial effect on chemotherapy-associated adverse effects and QOL in patients with cancer undergoing chemotherapy…”
“Patients who learn that they have HPV … are understandably frustrated because all we can do is monitor them for the abnormal changes associated with cancer. What we need is a safe, effective treatment for HPV before the cancer occurs”
According to research, “In the United States,Human papillomavirus is the most common sexually transmitted illness. About 70 percent of adults who are sexually active will contract the virus during their lifetimes…” Not only did I contract the HPV virus but I also was diagnosed with one of the cancers that HPV increases the risk of.
I was diagnosed with multiple myeloma in early 1994. I didn’t know it at the time but I also had the Human papillomavirus. While I can’t say that my MM was caused by Human papillomavirus I can say that HPV increased my risk of MM.
If I remember correctly I learned about AHCC possibly clearing the Human papillomavirus in about 2010. Like the study linked and excerpted below explains, I supplemented with AHCC for about six months. While my experience is hardly scientific, I no longer have the HPV virus and I have not relapsed from my MM.
Please keep in mind that I live an evidence-based, non-conventional, anti-MM lifestyle through nutrition, supplementation, detox., and other therapies. I will not chalk up not relapsing from MM solely from my AHCC supplementation. However I do think that if you have the Human papillomavirus virus you should supplement with AHCC.
Do you have Human papillomavirus? Have you been diagnosed with one of the cancers that the HPV virus increases the risk of?
“Could a Japanese mushroom extract be the cure for Human papillomavirus, the virus that causes cervical cancer?
It’s a potential breakthrough in treating the currently untreatable human papilloma virus (HPV) — one that comes directly from nature…
Smith noted that HPV is linked to 99 percent of cervical cancers cases, as well as cases of many other potentially fatal cancers. As it stands, there are no medications or supplements that can effectively treat HPV…
In the study, 10 women who had tested positive for Human papillomavirus were given AHCC once a day for up to six months. Upon retesting, five came back negative for the virus. In three of those women, the HPV stayed at bay after stopping AHCC treatment. The other two patients who tested negative are still in the study, aiming to complete a six-month treatment course of AHCC…
Is AHCC Safe to Use?
Do these results mean that doctors might one day recommend AHCC as a treatment for Human papillomavirus?
“If the larger study confirms our results, then yes, a clinician could recommend using AHCC as a nutritional supplement to treat Human papillomavirus infections,” Smith said…
Studies have already confirmed how AHCC operates in the immune system. It boosts the amount of natural killer cells, dendritic cells, and cytokines — all types of cells that help the body fight infections and suppress tumor growth…
Second Cancers Increasingly Common Among Human papillomavirus-Related Second Cancers
“Adults who survived Human papillomavirus-associated cancers appeared at a significant risk for HPV-associated second primary cancers, according a retrospective cohort study…
Additionally, the risk for developing most types of HPV-associated second primary cancers has increased over the last 4 decades…
Both men and women who had initial oropharyngeal cancers appeared to be at the highest risk for secondary primary cancers when assessing SIRs (men, 18; 95% CI, 16.9-19.1; women, 19.8; 95% CI, 18.4-21.4) and excess absolute risk per 10,000 person-years at risk (men, 61.5; women, 80.6)…”